FDA
approval
· 2019-05-02
FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved Rising Pharma Holdings' original ANDA for timolol maleate, a generic ophthalmic beta-blocker intended to reduce intraocular pressure in glaucoma an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TIMOLOL MALEATE (TIMOLOL MALEATE)